Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2013 (← Previous) (Next →)

Filing Date: Feb 13, 2014

Total Value: $1.072B (100.0% shares, 0.0% debt)

Holdings (34)

— Cyberonics, Inc. 11.9%
Value $128M Shares 1,951,581 Share Price $65.42 Est. Cost/Share $52.15 Unrealized @ Report Date —
UTHR United Therapeutics Corp 11.6%
Value $124M Shares 1,095,428 Share Price $113.08 * Est. Cost/Share $66.46 Unrealized @ Report Date +35.7%
— Auxilium Pharmaceuticals, Inc. 9.4%
Value $101M Shares 4,883,879 Share Price $20.73 Est. Cost/Share $17.45 Unrealized @ Report Date —
— Cubist Pharmaceuticals, Inc. 8.6%
Value $92.02M Shares 1,336,136 Share Price $68.87 Est. Cost/Share $56.19 Unrealized @ Report Date —
— Abiomed Inc. 6.7%
Value $71.86M Shares 2,687,347 Share Price $26.74 Est. Cost/Share $21.31 Unrealized @ Report Date —
— Intermune Inc. 5.2%
Value $56.26M Shares 3,819,606 Share Price $14.73 Est. Cost/Share $12.66 Unrealized @ Report Date —
— Questcor Pharmaceuticals, Inc. 4.9%
Value $52.49M Shares 963,995 Share Price $54.45 Est. Cost/Share $48.32 Unrealized @ Report Date —
BMRN Biomarin Pharmaceuticals, Inc 4.9%
Value $52.13M Shares 741,087 Share Price $70.35 * Est. Cost/Share $63.65 Unrealized @ Report Date +6.7%
STAA STAAR Surgical Company 4.9%
Value $52.04M Shares 3,214,253 Share Price $16.19 * Est. Cost/Share $8.10 Unrealized @ Report Date +65.2%
— AMAG Pharmaceuticals, Inc. 4.0%
Value $42.77M Shares 1,761,332 Share Price $24.28 Est. Cost/Share $22.29 Unrealized @ Report Date —
VNDA Vanda Pharmaceutical Inc. 3.7%
Value $40.19M Shares 3,238,624 Share Price $12.41 * Est. Cost/Share $7.72 Unrealized @ Report Date +30.7%
— Kythera BioPharm CMN 3.1%
Value $33.64M Shares 900,559 Share Price $37.35 Est. Cost/Share $38.50 Unrealized @ Report Date —
— Anacor Pharmaceuticals, Inc. 2.5%
Value $26.9M Shares 1,603,278 Share Price $16.78 Est. Cost/Share $5.59 Unrealized @ Report Date —
— Ariad Pharmaceuticals, Inc. 2.2%
Value $23.47M Shares 3,441,324 Share Price $6.82 Est. Cost/Share $6.82 Unrealized @ Report Date —
— Sequenom Inc. 2.1%
Value $21.98M Shares 9,394,627 Share Price $2.34 Est. Cost/Share $3.97 Unrealized @ Report Date —
— Momenta Pharmaceuticals, Inc. 1.9%
Value $20.46M Shares 1,157,276 Share Price $17.68 Est. Cost/Share $15.11 Unrealized @ Report Date —
— Alimera Sciences, Inc. 1.6%
Value $17.08M Shares 3,634,984 Share Price $4.70 Est. Cost/Share $4.88 Unrealized @ Report Date —
— Rigel Pharmaceuticals Inc. 1.4%
Value $14.87M Shares 5,217,001 Share Price $2.85 Est. Cost/Share $3.43 Unrealized @ Report Date —
— ViroPharma Incorporated 1.4%
Value $14.5M Shares 290,916 Share Price $49.85 Est. Cost/Share $28.65 Unrealized @ Report Date —
PRTA Prothena Corp PLC 1.3%
Value $14.25M Shares 537,418 Share Price $26.52 * Est. Cost/Share $22.48 Unrealized @ Report Date +11.6%
— NPS Pharmaceuticals 1.2%
Value $13.33M Shares 439,100 Share Price $30.36 Est. Cost/Share $30.36 Unrealized @ Report Date —
— QLT Inc. 1.1%
Value $11.44M Shares 2,053,311 Share Price $5.57 Est. Cost/Share $4.40 Unrealized @ Report Date —
— Clovis Oncology Inc. 1.1%
Value $11.26M Shares 186,900 Share Price $60.27 Est. Cost/Share $60.27 Unrealized @ Report Date —
FOLD Amicus Therapeutics, Inc. 0.9%
Value $9.42M Shares 4,008,576 Share Price $2.35 * Est. Cost/Share $3.07 Unrealized @ Report Date -28.6%
EXAS Exact Sciences Corp 0.9%
Value $9.233M Shares 785,776 Share Price $11.75 * Est. Cost/Share $12.83 Unrealized @ Report Date -10.6%
INSM Insmed, Inc. 0.5%
Value $4.967M Shares 292,199 Share Price $17.00 * Est. Cost/Share $10.67 Unrealized @ Report Date +43.5%
— Spectrum Pharmaceuticals Inc. 0.3%
Value $3.56M Shares 402,285 Share Price $8.85 Est. Cost/Share $7.48 Unrealized @ Report Date —
— AVEO Pharmaceuticals, Inc. 0.2%
Value $2.615M Shares 1,429,174 Share Price $1.83 Est. Cost/Share $2.50 Unrealized @ Report Date —
— Xoma Ltd. 0.2%
Value $1.724M Shares 256,100 Share Price $6.73 Est. Cost/Share $3.63 Unrealized @ Report Date —
CYTK Cytokinetics Inc. 0.1%
Value $1.513M Shares 232,808 Share Price $6.50 Est. Cost/Share $6.57 Unrealized @ Report Date 0.0%
— Hyperion Therapeutics 0.1%
Value $1.268M Shares 62,700 Share Price $20.22 Est. Cost/Share $22.00 Unrealized @ Report Date —
— Sophiris Bio Inc 0.1%
Value $1.084M Shares 292,900 Share Price $3.70 Est. Cost/Share $3.88 Unrealized @ Report Date —
— Align Technology, Inc. 0.0%
Value $445K Shares 7,788 Share Price $57.14 Est. Cost/Share $51.27 Unrealized @ Report Date —
— Celgene Corp. 0.0%
Value $438K Shares 2,590 Share Price $169.11 Est. Cost/Share $159.15 Unrealized @ Report Date —